Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma
Academic Radiology · 2023
DOI: 10.1016/j.acra.2023.02.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2023. Verfasst von Zhenkang Qiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Medical Center, The Affiliated Hospital of Qingdao University, 16 Jiangsu, 266003, Qingdao, Shandong Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Brachytherapy, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: Portal vein tumor thrombus (PVTT) seriously reduces the survival of patients with hepatocellular carcinoma (HCC). CT-guided iodine-125 (125I) brachytherapy has the advantage of a high local control rate and is minimally invasive. This study aims to evaluate the safety and efficacy of 125I brachytherapy for treating PVTT in HCC patients. MATERIALS AND METHODS: Thirty-eight patients diagnosed with HCC complicated with PVTT and treated with 125I brachytherapy for PVTT were included in this retrospective study. The local tumor control rate, local tumor progression-free survival, and overall survival (OS) were analyzed. Cox proportional hazards regression analysis was performed to identify predictors affecting survival. RESULTS: The local tumor control rate was 78.9% (30/38). The median local tumor progression-free survival was 11.6 (95% confidence interval [CI]: 6.7, 16.5) months, and the median overall survival was 14.5 (95% CI: 9.2, 19.7) months. Multivariate Cox analysis showed that age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interventional Medical Center, The Affiliated Hospital of Qingdao University, 16 Jiangsu, 266003, Qingdao, Shandong Province, China.
- Qingdao Municipal Center For Disease Control & Prevention, Qingdao Institute of Preventive Medicine, Qingdao, Shandong Province, China.
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
- Department of Interventional Medicine, Jimo District Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China.
- Interventional Medical Center, The Affiliated Hospital of Qingdao University, 16 Jiangsu, 266003, Qingdao, Shandong Province, China. Electronic address: derekqyfy@126.com.
Zitieren
APA
Qiu, Z., Yu, C., Qiu, X., Li, Q., Li, J., Chen, Z., Chang, S., Zhang, S., Fan, G., & Wang, S. (2023). Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. Academic Radiology. https://doi.org/10.1016/j.acra.2023.02.006
Vancouver
Qiu Z, Yu C, Qiu X, Li Q, Li J, Chen Z, et al. Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. Academic Radiology. 2023. doi:10.1016/j.acra.2023.02.006
BibTeX
@article{Qiu2023,
author = {Qiu, Zhenkang and Yu, Chunpeng and Qiu, Xiaofei and Li, Qun and Li, Jian and Chen, Zhao and Chang, Shuai and Zhang, Shuo and Fan, Gang and Wang, Song},
title = {Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma},
journal = {Academic Radiology},
year = {2023},
doi = {10.1016/j.acra.2023.02.006}
}
EUVIMED